As a co-investigator, Dr. Paller will be responsible for the severe eczema validation. She will oversee research staff and their training to document skin and administer an adaptation of the patient-oriented eczema measure. She will also oversee the assessment of severe eczema by a board-certified dermatologist and scoring of eczema severity. Dr. Paller will provide assistance with manuscript preparation and dissemination.
|Effective start/end date||7/1/22 → 6/30/23|
- Ann & Robert H. Lurie Children's Hospital of Chicago (901576-NU//5U01AI138907-04)
- National Institute of Allergy and Infectious Diseases (901576-NU//5U01AI138907-04)
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.